IL163984A0 - Method for producing crystals from active ingredients in medicaments, crystals obtained by said method, and use thereof in pharmaceutical formulation - Google Patents
Method for producing crystals from active ingredients in medicaments, crystals obtained by said method, and use thereof in pharmaceutical formulationInfo
- Publication number
- IL163984A0 IL163984A0 IL16398403A IL16398403A IL163984A0 IL 163984 A0 IL163984 A0 IL 163984A0 IL 16398403 A IL16398403 A IL 16398403A IL 16398403 A IL16398403 A IL 16398403A IL 163984 A0 IL163984 A0 IL 163984A0
- Authority
- IL
- Israel
- Prior art keywords
- crystals
- medicaments
- active ingredients
- pharmaceutical formulation
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10218106A DE10218106A1 (de) | 2002-04-23 | 2002-04-23 | Verfahren zum Herstellen von Kristallen von Arzneimittelwirkstoffen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
| PCT/EP2003/004153 WO2003090721A2 (de) | 2002-04-23 | 2003-04-22 | Verfahren zur herstellung von kristallen von arzneimittelwirkstoffen und deren verwendung in pharmazeutischen formulierungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL163984A0 true IL163984A0 (en) | 2005-12-18 |
Family
ID=29264786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16398403A IL163984A0 (en) | 2002-04-23 | 2003-04-22 | Method for producing crystals from active ingredients in medicaments, crystals obtained by said method, and use thereof in pharmaceutical formulation |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20030215516A1 (pl) |
| EP (1) | EP1523302A2 (pl) |
| JP (1) | JP2005535577A (pl) |
| KR (1) | KR20050003388A (pl) |
| CN (1) | CN1812767A (pl) |
| AU (1) | AU2003232490A1 (pl) |
| BR (1) | BR0309358A (pl) |
| CA (1) | CA2480130A1 (pl) |
| DE (1) | DE10218106A1 (pl) |
| IL (1) | IL163984A0 (pl) |
| MX (1) | MXPA04010466A (pl) |
| NO (1) | NO20045071L (pl) |
| PL (1) | PL371518A1 (pl) |
| RU (1) | RU2004134321A (pl) |
| WO (1) | WO2003090721A2 (pl) |
| ZA (1) | ZA200409398B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI365068B (en) * | 2005-05-20 | 2012-06-01 | Merck Sharp & Dohme | Formulations of suberoylanilide hydroxamic acid and methods for producing same |
| BRPI0708470A2 (pt) * | 2006-03-14 | 2011-05-31 | Merck & Co Inc | processo para a produção de partìculas cristalinas de um composto ativo orgánico, e, composição farmacêutica |
| DE102010003711B4 (de) * | 2010-04-08 | 2015-04-09 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoffpartikel |
| US9745250B2 (en) | 2014-05-13 | 2017-08-29 | Akzo Nobel Chemicals International B.V. | Process to crystallize chelating agents |
| CN108031142A (zh) * | 2017-12-13 | 2018-05-15 | 上海合全药物研发有限公司 | 一种简化的利用湿磨来制备大量微晶种的装置及方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB838654A (en) * | 1956-02-08 | 1960-06-22 | Upjohn Co | Steroids and the production thereof |
| US3226389A (en) * | 1962-01-04 | 1965-12-28 | Du Pont | 11,11,12,12-tetracyano-naphtho-2,6-quinodimethan and its anion-radical salts |
| CH627449A5 (de) * | 1977-03-25 | 1982-01-15 | Hoffmann La Roche | Verfahren zur herstellung von mikrokristallinem vitamin a-acetat, sowie von trockenen, frei-fliessenden praeparaten, in welchen vitamin a-acetat in mikrokristalliner form vorliegt. |
| DE2801705A1 (de) * | 1978-01-16 | 1979-07-19 | Metallgesellschaft Ag | Verfahren zur gewinnung von kaliumchlorid |
| DE3014160A1 (de) * | 1979-04-16 | 1980-10-30 | Lummus Co | Kristallisationsverfahren |
| DE3306250A1 (de) * | 1983-02-23 | 1984-08-23 | Basf Ag, 6700 Ludwigshafen | Sphaerische einkristalle fuer pharmazeutische zwecke |
| US4997637A (en) * | 1989-05-09 | 1991-03-05 | Occidental Chemical Corporation | Digestive crystallizing process and apparatus for purification of KC1 |
| FR2668945B1 (fr) * | 1990-11-12 | 1993-02-19 | Theramex | Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus. |
| DE4143631A1 (de) * | 1991-05-30 | 1998-04-16 | Dynamit Nobel Ag | Zerkleinerung von pulverförmigen Initialsprengstoffen |
| DE4244466C2 (de) * | 1992-12-24 | 1995-02-23 | Pharmatech Gmbh | Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten |
-
2002
- 2002-04-23 DE DE10218106A patent/DE10218106A1/de not_active Ceased
-
2003
- 2003-04-17 US US10/417,556 patent/US20030215516A1/en not_active Abandoned
- 2003-04-22 AU AU2003232490A patent/AU2003232490A1/en not_active Abandoned
- 2003-04-22 RU RU2004134321/15A patent/RU2004134321A/ru not_active Application Discontinuation
- 2003-04-22 CA CA002480130A patent/CA2480130A1/en not_active Abandoned
- 2003-04-22 KR KR10-2004-7017080A patent/KR20050003388A/ko not_active Application Discontinuation
- 2003-04-22 IL IL16398403A patent/IL163984A0/xx unknown
- 2003-04-22 EP EP03747106A patent/EP1523302A2/de not_active Withdrawn
- 2003-04-22 JP JP2003587358A patent/JP2005535577A/ja not_active Withdrawn
- 2003-04-22 PL PL03371518A patent/PL371518A1/pl not_active Application Discontinuation
- 2003-04-22 WO PCT/EP2003/004153 patent/WO2003090721A2/de active Application Filing
- 2003-04-22 BR BR0309358-1A patent/BR0309358A/pt not_active IP Right Cessation
- 2003-04-22 CN CNA038092123A patent/CN1812767A/zh active Pending
- 2003-04-22 MX MXPA04010466A patent/MXPA04010466A/es unknown
-
2004
- 2004-11-22 ZA ZA200409398A patent/ZA200409398B/en unknown
- 2004-11-22 NO NO20045071A patent/NO20045071L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2480130A1 (en) | 2003-11-06 |
| KR20050003388A (ko) | 2005-01-10 |
| DE10218106A1 (de) | 2003-11-20 |
| PL371518A1 (pl) | 2005-06-27 |
| CN1812767A (zh) | 2006-08-02 |
| RU2004134321A (ru) | 2005-10-10 |
| EP1523302A2 (de) | 2005-04-20 |
| WO2003090721A2 (de) | 2003-11-06 |
| US20030215516A1 (en) | 2003-11-20 |
| BR0309358A (pt) | 2005-02-22 |
| ZA200409398B (en) | 2006-06-28 |
| WO2003090721A3 (de) | 2005-02-24 |
| JP2005535577A (ja) | 2005-11-24 |
| MXPA04010466A (es) | 2004-12-13 |
| NO20045071L (no) | 2005-01-21 |
| AU2003232490A1 (en) | 2003-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL171683A (en) | Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment | |
| IL163831A (en) | Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof | |
| HUP0402588A3 (en) | Quinazoline derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
| WO2005041925A3 (en) | Compositions and dosage forms for enhanced absorption | |
| IL163894A (en) | 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments | |
| IL212477A0 (en) | Biaryl heterocyclic compounds, methods of making the same, pharmaceutical compositions comprising them and their use in the preparation of medicaments | |
| AU2003244632A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| IL165977A (en) | Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same | |
| IL213597A0 (en) | Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
| IL167038A (en) | Pyrazole derivatives, pharmaceutical compositions containing the same, use thereof in the manufacture of medicaments and intermediate for production thereof | |
| ATE397440T1 (de) | Pharmazeutische zubereitungen von antineoplastischen wirkstoffen, insbesondere temozolomid, verfahren zu ihrer herstellung und deren verwendung | |
| IL162765A (en) | Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use | |
| IL195294A (en) | A process for the manufacture of high purity spinamide or relapinamide, their use in the preparation of medicaments and medicinal preparations containing them | |
| EP1478345A4 (en) | NOVEL PHARMACEUTICAL DOSAGE FORMS AND PROCESS FOR PRODUCTION OF SAID DOSAGE FORMS | |
| HUP0303891A3 (en) | Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| AU2002233463A1 (en) | Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use | |
| PL370554A1 (pl) | Nowe związki i ich zastosowanie w medycynie, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierajace te związki | |
| AU2003244649A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| IL162669A0 (en) | Antichlinergic agents, method for producing the same and use thereof as medicaments | |
| IL204947A0 (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them | |
| IL159217A0 (en) | An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine | |
| FR2850576B1 (fr) | Composition comprenant un melange de principes actifs, et procede de preparation | |
| IL175023A0 (en) | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same | |
| IL214387A (en) | History of tryptamine, method for their preparation and use for the preparation of pharmaceuticals and for the preparation of tryptamine | |
| AU2003297199A8 (en) | Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |